Lippo Cikarang Tbk vs Merck Tbk. — how do they compare? Lippo Cikarang Tbk trades at Rp510 (market cap 2.62T, 276.7K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Lippo Cikarang Tbk is the larger of the two by market cap, and Lippo Cikarang Tbk is more actively traded (276.7K versus 37.6K). Which is the better fit depends on your goals.
| LPCK | MERK | |
|---|---|---|
Market Cap | 2.62T | 1.7T |
Volume | 276.7K | 37.6K |
Lot | 2.77K | 376 |
Turnover | 143.99M | 144.47M |
Average Price | 520.38 | 3,842.23 |
Value | 143.99M | 144.47M |
Indicative Equilibrium Price | 510 | 3,840 |
Indicative Equilibrium Volume | 1 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo Cikarang Tbk was established in the Republic of Indonesia the framework of the Domestic Capital Investment Law on July 20, 1987 based on Notarial Deed No.43 of Hendra Karyadi, S.H., as amended by Notarial Deed No. 63 of the same notary dated April 22, 1998.
Read more on LPCK →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →